What Doctors Need To Know
Understand ED referrals from the pharmacist and your role in your patients’ treatment journeys
The launch of VIAGRA connect as an over-the-counter (OTC) medicine makes it more convenient for men with erectile dysfunction (ED) to access treatment through a regulated route. For some men, it could be their first direct interaction with a healthcare professional in relation to ED.
The pharmacist's role in supplying VIAGRA connect goes beyond offering convenient product access, they will have the opportunity to provide lifestyle advice and encourage men with ED to visit their doctor for a health check. ED may occur for a number of reasons, but one of the major causes is the development of underlying cardiovascular disease (CVD).1 Identifying these men as early as possible provides a good opportunity not only to deal with their ED but also the underlying cause(s) of their ED – potentially leading to a general improvement in men’s health.
ED and CVD Risk
Evidence suggests that the severity of ED correlates to the degree of underlying CVD.*2 Over time, larger arteries tolerate a greater plaque burden without compromising blood flow compared with smaller arteries, such as those in the penis that block more quickly. The narrower penile artery is more likely to occlude at an earlier stage of atherosclerosis than the coronary artery. ED symptoms can therefore be an early warning sign of plaque build-up in larger arteries supplying blood to the heart and brain.3,4
For many men, ED symptoms can be a sign that blood flow to the penis may already be restricted.2,3,5
Delays in seeking advice from a healthcare professional means that men with ED and underlying CVD* could go on to experience a major cardiac event within 5–10 years of experiencing ED symptoms.6
*Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels and includes angina, arrhythmias, heart attacks and strokes. The main risk factors for CVD are: High blood pressure, diabetes, high cholesterol, smoking, inactivity or being overweight/obese.7
The VIAGRA connect Checklist
Pharmacists have been provided with extensive training to help them manage the OTC supply of VIAGRA connect. As part of the supply process, they will ask patients a series of questions to determine suitability. These questions are shown in the VIAGRA connect Checklist.
The Checklist is designed to assess the following elements:
The identification of appropriate patients i.e. those with ED
Concomitant medication to identify contraindicated drug use and concomitant medical conditions which would preclude the man from using the OTC product
The VIAGRA connect Checklist includes two tear-off slips. One slip is for patients who the pharmacist considers are suitable for VIAGRA connect. The pharmacist can give this to the man as a record and reminder of the date the product was first supplied. The slip may be used to facilitate resupply requests in the future provided there is no change in the man’s cardiovascular health, medication or medical conditions. These men will be directed by the pharmacist to visit their GP within 6 months of first supply to assess the underlying cause of their ED.
The other tear-off slip is for patients who are deemed unsuitable for VIAGRA connect.The pharmacist can provide a written reason for non-supply so that the man can bring this to his GP to facilitate the ED conversation.
As a result, GPs are likely to see an increase in patient referrals for ED from community pharmacy.
- NICE Clinical Knowledge Summaries. Erectile dysfunction. Accessed October 2018.
- Nehra AJ, et al. Mayo Clin Proc 2012;87:766–78.
- Montorsi P, et al. Am J Cardiol 2005;96:19M–23M.
- Kirby M & Jackson G. Trends Urol Men Health 2011;2.
- Solomon H, et al. Heart 2003;89:251–4.
- Miner M. J Androl 2011;32:125–34.
- NHS UK website. Accessed October 2018.